Rafael M Prieto1, M Fiol, J Perello, R Estruch, E Ros, P Sanchis, F Grases. 1. Laboratory of Renal Lithiasis Research, University Institute of Health Sciences Research IUNICS, University of Balearic Islands, 07122 Palma, Spain. rafelm.prieto@uib.es
Abstract
BACKGROUND: Important health benefits have been reported recently to phytate intake. This includes the prevention of pathological calcifications such as renal calculi, dental calculi and cardiovascular calcification, due its action as crystallization inhibitor of calcium salts, and as preventive of cancer. AIM OF STUDY: The aim of this study was to establish a relation between the intake of phytate, through consumption of typical components of the Mediterranean diet (including nuts), and its excretion in urine. METHODS: This study recruited participants from subjects included in a larger trial (PREDIMED) of food habits, that were assigned to one of two diet groups: (1) the Mediterranean diet with low proportion of phytate-rich food group, where participants were asked to maintain their usual diet; and (2) the Mediterranean diet with high proportion of phytate-rich food group, where participants were asked to increase phytate-rich foods in their diet. Phytate intake was assessed on the basis of a food frequency questionnaire. Urinary phytate excretion was determined in 2-h urine samples. RESULTS: The overall phytate consumption of the Mediterranean diet with high proportion of phytate-rich food group (672 +/- 50 mg) was significantly higher than the Mediterranean diet with low proportion of phytate-rich food group (422 +/- 34 mg), representing a 59% difference. Urinary phytate excretion was also significantly higher (54%) in the Mediterranean diet with high proportion of phytate-rich food group (1,016 +/- 70 microg/L) than the Mediterranean diet with low proportion of phytate-rich food group (659 +/- 45 microg/L). CONCLUSIONS:Mediterranean diets high in whole cereals, legumes and nuts compared to Mediterranean diets low in these phytate-rich foods increase the urinary phytate excretion in humans.
RCT Entities:
BACKGROUND: Important health benefits have been reported recently to phytate intake. This includes the prevention of pathological calcifications such as renal calculi, dental calculi and cardiovascular calcification, due its action as crystallization inhibitor of calcium salts, and as preventive of cancer. AIM OF STUDY: The aim of this study was to establish a relation between the intake of phytate, through consumption of typical components of the Mediterranean diet (including nuts), and its excretion in urine. METHODS: This study recruited participants from subjects included in a larger trial (PREDIMED) of food habits, that were assigned to one of two diet groups: (1) the Mediterranean diet with low proportion of phytate-rich food group, where participants were asked to maintain their usual diet; and (2) the Mediterranean diet with high proportion of phytate-rich food group, where participants were asked to increase phytate-rich foods in their diet. Phytate intake was assessed on the basis of a food frequency questionnaire. Urinary phytate excretion was determined in 2-h urine samples. RESULTS: The overall phytate consumption of the Mediterranean diet with high proportion of phytate-rich food group (672 +/- 50 mg) was significantly higher than the Mediterranean diet with low proportion of phytate-rich food group (422 +/- 34 mg), representing a 59% difference. Urinary phytate excretion was also significantly higher (54%) in the Mediterranean diet with high proportion of phytate-rich food group (1,016 +/- 70 microg/L) than the Mediterranean diet with low proportion of phytate-rich food group (659 +/- 45 microg/L). CONCLUSIONS: Mediterranean diets high in whole cereals, legumes and nuts compared to Mediterranean diets low in these phytate-rich foods increase the urinary phytate excretion in humans.
Authors: Ramon Estruch; Miguel Angel Martínez-González; Dolores Corella; Jordi Salas-Salvadó; Valentina Ruiz-Gutiérrez; María Isabel Covas; Miguel Fiol; Enrique Gómez-Gracia; Mari Carmen López-Sabater; Ernest Vinyoles; Fernando Arós; Manuel Conde; Carlos Lahoz; José Lapetra; Guillermo Sáez; Emilio Ros Journal: Ann Intern Med Date: 2006-07-04 Impact factor: 25.391
Authors: F Grases; J Perelló; P Sanchis; B Isern; R M Prieto; A Costa-Bauzá; C Santiago; M L Ferragut; G Frontera Journal: J Periodontal Res Date: 2008-10-22 Impact factor: 4.419
Authors: Fèlix Grases; Antonia Costa-Bauzá; Carlo R Bonarriba; Enrique C Pieras; Rafael A Fernández; Adrián Rodríguez Journal: Urolithiasis Date: 2014-08-03 Impact factor: 3.436
Authors: Carrie R Daniel; Yikyung Park; Wong-Ho Chow; Barry I Graubard; Albert R Hollenbeck; Rashmi Sinha Journal: Am J Clin Nutr Date: 2013-03-20 Impact factor: 7.045
Authors: Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid Journal: Cochrane Database Syst Rev Date: 2020-08-21
Authors: Lee Hooper; Nicole Martin; Oluseyi F Jimoh; Christian Kirk; Eve Foster; Asmaa S Abdelhamid Journal: Cochrane Database Syst Rev Date: 2020-05-19
Authors: Carlos Fernández-Palomeque; Andres Grau; Joan Perelló; Pilar Sanchis; Bernat Isern; Rafel M Prieto; Antonia Costa-Bauzá; Onofre J Caldés; Oriol Bonnin; Ana Garcia-Raja; Armando Bethencourt; Felix Grases Journal: PLoS One Date: 2015-08-31 Impact factor: 3.240
Authors: Pilar Sanchis; Marilisa Molina; Francisco Berga; Elena Muñoz; Regina Fortuny; Antonia Costa-Bauzá; Felix Grases; Juan Manuel Buades Journal: Nutrients Date: 2019-12-25 Impact factor: 5.717